CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Explore which Low Cost Dividend ETF to invest in right now. We compare costs, yields, and diversification to help you decide efficiently.
27,336 articlesCVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
A modular housing developer is pushing into dense city towers, pairing off-site production with new financing models ...
Two former governors unveil a bipartisan coalition designed to prepare America’s workforce for an AI-driven future, w...
Gas prices are pushing households to rely more on credit as fuel costs take a larger share of income. The trend shows...
Strategy’s market value has slipped below the value of its own Bitcoin holdings, reversing years of a premium for BTC...
Google says a criminal group attempted to use AI to exploit a zero-day vulnerability, marking a turning point in cybe...
A remarriage at 62 does not automatically end survivor benefits. The aging rule remains in effect, allowing many wido...
A rare can shortage is turning a familiar cola into a symbol of status in India’s urban youth. This story examines ho...
Ripple's XRP is edging higher as derivatives data shows falling open interest. Traders wonder whether this is short-c...
New risk signals emerge as the S&P 500 grows more concentrated. Top 10 names and chipmakers now drive most of the mar...
The annual Sun Valley meeting is pivoting from legacy media power to AI and software influence, signaling a new era f...
Intel’s stock has surged on AI-driven catalysts, but traders are weighing whether the rally can continue or give back...